CN104127838A - Traditional Chinese medicine prescription for treating cancer - Google Patents
Traditional Chinese medicine prescription for treating cancer Download PDFInfo
- Publication number
- CN104127838A CN104127838A CN201410321821.5A CN201410321821A CN104127838A CN 104127838 A CN104127838 A CN 104127838A CN 201410321821 A CN201410321821 A CN 201410321821A CN 104127838 A CN104127838 A CN 104127838A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- chinese medicinal
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicine, and specially discloses a traditional Chinese medicine prescription for treating cancer. The traditional Chinese medicine prescription is prepared by compounding roasted ginger, antler gum, cassia twig, prepared rehmannia root, asarum herb, ephedra stem, and licorice according to a certain weight ratio. The prescription has the advantages of simple preparation, good absorption effect, prominent curative effect, no side effect, and high safety, and can relieve symptoms for patients in a short time.
Description
(1) technical field
The invention belongs to the field of Chinese medicines, particularly a kind of Chinese medicinal formulae for the treatment of cancer.
(2) background technology
Cancer is the common frdquently encountered disease of serious harm human health, is the first disease of harm humans life.The traditional Chinese medical science is thought, healthy energy virtual loss, and when namely inside of human body environmental stability and body internal and external equilibrium are destroyed, cancerigenic factor just can play a role and cause the formation of cancer, and makes cancer be infiltrated, spread and shift.
The current treatment for cancer, although also there are some, treat this sick Chinese patent medicine, but it is not fairly obvious to meet effect, Most patients still selects doctor trained in Western medicine to treat, however the conventional radiotherapy of doctor trained in Western medicine, the Therapeutic Method problems such as all ubiquity side effect is high, effect duration is short, relapse rate is high of chemotherapy.
(3) summary of the invention
The present invention, in order to make up the deficiencies in the prior art, provides a kind of Chinese medicinal formulae of preparing treatment cancer easy, evident in efficacy.
The present invention is achieved through the following technical solutions:
Treat a Chinese medicinal formulae for cancer, comprise the raw material of following parts by weight:
2.5 ~ 50 parts of Rhizoma Zingiberis Preparatums, 5 ~ 10 parts of Colla cornus cervis, 2.5 ~ 10 parts of Ramulus Cinnamomi, 5 ~ 10 parts of Radix Rehmanniae Preparata, 1.5 ~ 5 parts of Herba Asaris, 1.5 ~ 10 parts, Herba Ephedrae, 2 ~ 15 parts, Radix Glycyrrhizae.
According to the weight situation of the state of an illness, in raw material, also can add the Semen Sinapis Albae of 2.5 ~ 10 parts.
Its preferably proportioning raw materials be:
6 parts of Rhizoma Zingiberis Preparatums, 8 parts of Colla cornus cervis, 6 parts of Ramulus Cinnamomi, 10 parts of Radix Rehmanniae Preparata, 3 parts of Herba Asaris, 5 parts, Herba Ephedrae, 10 parts, Radix Glycyrrhizae; Wherein, can add the Semen Sinapis Albae of 5 parts.
The present invention can be made as tablet, decoction or injection according to patient's requirement.
Solution of the present invention is invention mechanism and the Therapeutic Principle to cancer based on motherland's medical science, with reference to modern medical theory, take strengthening vital QI to eliminate pathogenic factors as main, take inrigorating qi and promoting blood circulation, warming the meridian is terrified, eliminating stasis and resolving masses and making laws, select pure natural Chinese herbal medicine, by theory of Chinese medical science prescription, through strictly screening, in conjunction with traditional handicraft, combine.
The pharmaceutical properties that the present invention adopts is:
Rhizoma Zingiberis Preparatum: warming middle-JIAO to stop diarrhea, warming the meridian for stopping bleeding.Cure mainly deficiency and coldness epigastric pain, vomiting, dysentery, spits blood, has blood in stool, metrorrhagia;
Colla cornus cervi: the kidney warming benefit essence, nourishing blood and preventing abortion, hemostasis.Cure mainly asthenia weakness and emaciation, dizziness and tinnitus, soreness of the waist and knees, sexual impotence spermatorrhea, infertility, frequent fetal movement, bleeding not during menses, spits blood, epistaxis, spitting of blood, hematuria, carbuncle of yin nature;
Ramulus Cinnamomi: expelling cold and relieving exterior syndrome, warming the meridian, activates yang.Cure mainly exterior syndrome due to wind-cold, arthralgia due to cold-dampnes, extreme cold of the limbs, amenorrhea dysmenorrhea , mass in the abdomen caking, the thoracic obstruction, cardiopalmus, phlegm retention, dysuria;
Radix Rehmanniae Preparata: the YIN nourishing of enriching blood, beneficial essence is filled out marrow.Cure mainly blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, metrorrhagia is more than, hepatic and renal YIN deficiency, hectic fever night sweat, seminal emission sexual impotence, sterility and infertility, soreness of the waist and knees, Hiccough and deaf, the head is dim-sighted, and early whitening of beard and hair is quenched one's thirst, constipation, the dyspnea with rapid and short breath of suffering from a deficiency of the kidney;
Herba Asari: cold expelling dispels the wind, pain relieving, warming the lung to resolve fluid-retention, sensible.Cure mainly exterior syndrome due to wind-cold, headache, toothache, rheumatic arthralgia, phlegm retention cough with asthma, nasal obstruction, nasal sinusitis, aphtha;
Herba Ephedrae: relieving the exterior syndrome by diaphoresis, depressed lung-energy dispersing, inducing diuresis to remove edema.Cure mainly chill exterior syndrome, cough and asthma, edema due to wind pathogen, dysuria, rheumatic arthralgia, numbness of the skin, rubella pruritus, carbuncle of yin nature sucutaneous nodule;
Radix Glycyrrhizae: and middle emergency, lung moistening, removing toxic substances, coordinating the actions of various ingredients in a prescription.Process with controlling weakness of the spleen and stomach asthenia lack of appetite, stomachache loose stool, the anxious pain of extremity contraction, cardiopalmus, hysteria, consumptive lung disease cough; Raw with controlling laryngopharynx swelling and pain, carbuncle pyogenic infections from tumour or sore, infantile carbuncle, and medicine, alimentary toxicosis;
Semen Sinapis Albae: promoting the circulation of QI dry phlegm, mass dissipating and swelling eliminating.Cure mainly cough with asthma abundant expectoration, fullness in the chest and hypochondriac pain, numb limbs and tense tendons, arthralgia, multiple abscess caused by damp-phlegm, carbuncle of yin nature toxic swelling.
The present invention has mediator's body immunity function, strengthens phagocytic activity and the metabolic activity of human body macrophage, kills and wounds cancerous cell and protects normal health matrix cells, and the transfer of inhibition tumor cell and regeneration, promote rehabilitation function after being ill; Clinical treatment for various different tumors, each phase tumor also can be used in conjunction with operation, radiotherapy, chemotherapy simultaneously, is state of an illness long-term remission, has the effect that does not shift, do not recur.
Use clinical trial of the present invention as follows:
(1) clinical data
Choosing 100 routine tumor patients is treatment group, wherein, and the 1st phase tumor patient 35 people, the 2nd phase tumor patient 30 people, the 3rd phase tumor patient 35 people.
(2) Therapeutic Method:
The 1st phase tumor patient is taken medicine 3 months, and the 2nd phase tumor patient is taken medicine 6 months, and every 2 axles carry out x-ray or hemogram checking once, the 3rd phase tumor patient is taken medicine 6 months, and within every 2 weeks, carry out x-ray, hemogram and the inspection of Liver and kidney situation once, and take medicine after end, check the whole emergencing testeding projects of tumor.
(3) efficacy assessment standard:
The present invention is mainly used in treating various cancers and each phase cancer, therefore symptom improvement situation and every detection index are as curative effect judging standard, is divided into following four kinds:
Cure: x-ray, fiberscopy focus all absorb, and clinical in various malaise symptoms, indices inspection is normal.
Effective: after drug administration, tumor focus disappears substantially, every Index for examination is tending towards normally, and drug withdrawal is after two weeks, and clinical various symptoms and sign still maintain normal person.
Effective: remission rate after taking medicine, in X-ray film, tumor maximum gauge is multiplied by before its perpendicular diameter is treated and dwindles more than 50%.
Invalid: remission rate after taking medicine, in X-ray film, tumor maximum gauge is multiplied by before its perpendicular diameter is treated and dwindles below 50%.
(4) therapeutic effect:
Clinical cure: the 1st phase tumor patient 35 examples, the 2nd phase patient 20 examples, the 3rd phase patient 18 examples; Effective: the 2nd phase patient 6 examples, the 3rd phase patient 11 examples; Effective: the 2nd phase patient 3 examples, the 3rd phase patient 4 examples; Invalid: the 2nd phase patient 1 example, the 3rd phase patient 2 examples.Effective percentage 97%, cure rate 73%.
The present invention prepares simply, and good absorbing effect is evident in efficacy, has no side effect, safe, is conducive to sufferer and alleviates in time condition of illness.
(4) specific embodiment
1: the 1 phase patient medication proportioning raw materials of embodiment
Rhizoma Zingiberis Preparatum 2.5g, Colla cornus cervi 5g, Ramulus Cinnamomi 2.5g, Radix Rehmanniae Preparata 5g, Herba Asari 1.5g, Herba Ephedrae 1.5g, Radix Glycyrrhizae 2g.
2: the 2 phase patient medication proportioning raw materials of embodiment
Rhizoma Zingiberis Preparatum 6g, Colla cornus cervi 8g, Ramulus Cinnamomi 6g, Radix Rehmanniae Preparata 10g, Herba Asari 3g, Herba Ephedrae 5g, Radix Glycyrrhizae 10g, Semen Sinapis Albae 2.5g.
3: the 3 phase patient medication proportioning raw materials of embodiment
Rhizoma Zingiberis Preparatum 20g, Colla cornus cervi 10g, Ramulus Cinnamomi 10g, Radix Rehmanniae Preparata 10g, Herba Asari 5g, Herba Ephedrae 10g, Radix Glycyrrhizae 15g, Semen Sinapis Albae 5g.
Claims (5)
1. a Chinese medicinal formulae for the treatment of cancer, is characterized in that: the raw material that comprises following parts by weight: 2.5 ~ 50 parts of Rhizoma Zingiberis Preparatums, 5 ~ 10 parts of Colla cornus cervis, 2.5 ~ 10 parts of Ramulus Cinnamomi, 5 ~ 10 parts of Radix Rehmanniae Preparata, 1.5 ~ 5 parts of Herba Asaris, 1.5 ~ 10 parts, Herba Ephedrae, 2 ~ 15 parts, Radix Glycyrrhizae.
2. the Chinese medicinal formulae for the treatment of cancer according to claim 1, is characterized in that: described raw material comprises the Semen Sinapis Albae of 2.5 ~ 10 parts.
3. Chinese medicinal formulae according to claim 1, is characterized in that: the raw material that comprises following parts by weight: 6 parts of Rhizoma Zingiberis Preparatums, 8 parts of Colla cornus cervis, 6 parts of Ramulus Cinnamomi, 10 parts of Radix Rehmanniae Preparata, 3 parts of Herba Asaris, 5 parts, Herba Ephedrae, 10 parts, Radix Glycyrrhizae.
4. according to the Chinese medicinal formulae of the treatment cancer described in claim 2 or 3, it is characterized in that: described raw material comprises the Semen Sinapis Albae of 5 parts.
5. according to the Chinese medicinal formulae described in claim 1,2 or 3, it is characterized in that: described prescription is tablet, decoction or injection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410321821.5A CN104127838A (en) | 2014-07-05 | 2014-07-05 | Traditional Chinese medicine prescription for treating cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410321821.5A CN104127838A (en) | 2014-07-05 | 2014-07-05 | Traditional Chinese medicine prescription for treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104127838A true CN104127838A (en) | 2014-11-05 |
Family
ID=51800860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410321821.5A Pending CN104127838A (en) | 2014-07-05 | 2014-07-05 | Traditional Chinese medicine prescription for treating cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104127838A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107595916A (en) * | 2017-09-26 | 2018-01-19 | 陈帼英 | The Chinese medicinal formulae and application method of a kind for the treatment of cancer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0796609A2 (en) * | 1996-03-18 | 1997-09-24 | Suntory Limited | Antialopecia agent |
CN102309731A (en) * | 2010-06-30 | 2012-01-11 | 杨永江 | Traditional Chinese medicine decoction for treating tuberculous arthritis |
-
2014
- 2014-07-05 CN CN201410321821.5A patent/CN104127838A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0796609A2 (en) * | 1996-03-18 | 1997-09-24 | Suntory Limited | Antialopecia agent |
CN102309731A (en) * | 2010-06-30 | 2012-01-11 | 杨永江 | Traditional Chinese medicine decoction for treating tuberculous arthritis |
Non-Patent Citations (3)
Title |
---|
唐先平等: "《肿瘤临床常用中药指南》", 30 November 2005, 科学技术文献出版社 * |
施航: "阳和汤合帕米膦酸二钠治疗恶性肿瘤骨痛观察", 《实用中医药杂志》 * |
马红莲: "动脉硬化闭塞症的治疗进展", 《山西中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107595916A (en) * | 2017-09-26 | 2018-01-19 | 陈帼英 | The Chinese medicinal formulae and application method of a kind for the treatment of cancer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102362947B (en) | Chinese medicine for treating cough | |
CN102145114B (en) | Novel traditional Chinese medicine for treating cold | |
CN102908606A (en) | Traditional Chinese medicine for treating pregnancy vomiting | |
CN101954027B (en) | Traditional Chinese medicine for curing phthisis | |
CN105343645A (en) | External traditional Chinese medicine ointment for treating verruca plana | |
CN102631512B (en) | Traditional Chinese medicine composition for curing chronic colitis | |
CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
CN103432561B (en) | Traditional Chinese medicament for treating phlebitis | |
CN101439149B (en) | Chinese medicinal composition for treating gastric ulcer, gastrorrhagia and gastric perforation | |
CN104127838A (en) | Traditional Chinese medicine prescription for treating cancer | |
CN103860955A (en) | Traditional Chinese medicine combination for treating human papillomavirus infection and preparation method of traditional Chinese medicine combination | |
CN106344754A (en) | Unguent for treating haemorrhoids | |
CN105213758A (en) | A kind of Chinese medicine composition for the treatment of chronic pneumonia and preparation method thereof | |
CN105267630A (en) | Traditional Chinese medicine for treating tinnitus | |
CN103845690A (en) | Medicament for treating geriatric depression | |
CN103585403A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
CN103127295B (en) | One is treated leukemic Chinese medicine | |
CN103417787A (en) | Traditional Chinese medicine drug granules used for prevention and treatment of pig dysentery and preparation method of traditional Chinese medicine drug granules | |
CN102961454A (en) | Method for treating scapulohumeral periarthritis and preparation method for same | |
CN103301334B (en) | Traditional Chinese medicine for treating children cough | |
CN102580047A (en) | Chinese medicinal pills for treating kidney-deficiency asthma | |
CN102406913A (en) | Chinese medicinal composition for treating melancholia | |
CN107296830A (en) | A kind of Huoxue Herbs | |
CN101983719A (en) | Novel medicament for treating lung cancer | |
CN106177561A (en) | One treats phthisical Chinese medicine composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141105 |